Literature DB >> 28522712

Draft Genome Sequence of Pseudomonas sp. Strain Ep R1 Isolated from Echinacea purpurea Roots and Effective in the Growth Inhibition of Human Opportunistic Pathogens Belonging to the Burkholderia cepacia Complex.

Valentina Maggini1,2,3, Luana Presta1, Elisangela Miceli1, Marco Fondi1, Emanuele Bosi1, Carolina Chiellini1, Camilla Fagorzi1, Patrizia Bogani1, Vincenzo Di Pilato4, Gian Maria Rossolini2,5, Alessio Mengoni1, Fabio Firenzuoli3, Elena Perrin1, Renato Fani6.   

Abstract

In this announcement, we detail the draft genome sequence of the Pseudomonas sp. strain Ep R1, isolated from the roots of the medicinal plant Echinacea purpurea The elucidation of this genome sequence may allow the identification of genes associated with the production of antimicrobial compounds.
Copyright © 2017 Maggini et al.

Entities:  

Year:  2017        PMID: 28522712      PMCID: PMC5477323          DOI: 10.1128/genomeA.00351-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Endophytic bacterial communities inhabiting the rhizosphere or internal tissues of the medicinal plants (MPs) may contribute to the therapeutic properties of these plants (1). Here we report on the draft genome sequence of Pseudomonas sp. strain Ep R1, a strain isolated from the roots of Echinacea purpurea, an MP with immunomodulant, antiviral, and antimicrobial activity (2). The E. purpurea bacterial endophytes were isolated and molecular and phenotypic characterizations were conducted (3). In particular, Pseudomonas sp. Ep R1 showed the ability to inhibit the growth of other E. purpurea endophytes (4) and of cystic fibrosis bacterial pathogens belonging to the Burkholderia cepacia complex (5). Moreover, it has been demonstrated to be highly (50 μg/ml) resistant to chloramphenicol and streptomycin (6). The genome sequence of Pseudomonas sp. Ep R1 was determined by a 2- × 300-bp paired-end approach using the MiSeq sequencing system (Illumina Inc., San Diego, CA). A total of 1,148,852 paired-end reads were obtained, representing approximately 100× coverage of the whole genome. De novo assembly was performed using SPAdes 2.3 (7), which generated 363 contigs. Contigs with length less than 2,000 bp were discarded. The remaining contigs were used for a multidraft-based analysis using genome sequences of 13 Pseudomonas strains retrieved from the NCBI database (P. aeruginosa PAO1, P. alkylphenolia KL28, P. denitrificans ATCC 13867, P. entomophila L48, P. fluorescens F113, P. fulva 12-X, P. knackmussii B13, P. mendocina ymp, P. protegens CHA0, P. putida KT2440, P. resinovorans NBRC, P. stutzeri CGMCC, and P. syringae pv. tomato DC3000) through MeDuSa scaffolder (8). The final version of the draft genome assembly of Pseudomonas sp. Ep R1 is 6,797,087 bp long and embeds 158 contigs (the longest of which is 1,954,067 bp long). The G+C content is 65.5%, similar to that of other Pseudomonas genomes sequenced so far. Automated annotation of the Pseudomonas sp. Ep R1 draft genome sequence using the NCBI Prokaryotic Genome Annotation Pipeline detected 6,001 protein-coding genes, 67 RNA-coding genes (7 complete rRNAs, 56 tRNAs, 4 noncoding RNAs [ncRNAs]), and 173 pseudogenes. Genes involved in the biosynthesis of secondary metabolites with antimicrobial activity were searched. The analysis was performed within an antiSMASH shell (9), which revealed that the Pseudomonas Ep R1 genome harbors 6 clusters involved in the biosynthesis of streptomycin, stenothricin, pimaricin, type 3 polyketide synthase (T3PKS), siderophore (desferrioxamine B), and nonribosomal peptide synthetase (NRPS) (amychelin). Moreover, the genome sequence was analyzed through CARD (10), which led to the identification of several genes (mexABEJKMNW, omrMN, katG, triC, mfd, and mdtC) putatively involved in antibiotic resistance, some conferring specific resistance to fluoroquinolone, mupirocin, beta-lactam, aminocoumarin molecules, and others involved in regulatory or inactivating systems and efflux pumps.

Accession number(s).

This whole-genome shotgun project has been deposited in GenBank under the accession no. MWTQ00000000. The version described in this paper is the version MWTQ00000000.1.
  10 in total

Review 1.  Endophytes as sources of bioactive products.

Authors:  Gary A Strobel
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

2.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

3.  Endophytic and rhizospheric bacterial communities isolated from the medicinal plants Echinacea purpurea and Echinacea angustifolia.

Authors:  Carolina Chiellini; Isabel Maida; Giovanni Emiliani; Alessio Mengoni; Stefano Mocali; Arturo Fabiani; Sauro Biffi; Valentina Maggini; Luigi Gori; Alfredo Vannacci; Eugenia Gallo; Fabio Firenzuoli; Renato Fani
Journal:  Int Microbiol       Date:  2014-09       Impact factor: 2.479

4.  MeDuSa: a multi-draft based scaffolder.

Authors:  Emanuele Bosi; Beatrice Donati; Marco Galardini; Sara Brunetti; Marie-France Sagot; Pietro Lió; Pierluigi Crescenzi; Renato Fani; Marco Fondi
Journal:  Bioinformatics       Date:  2015-03-25       Impact factor: 6.937

5.  Antagonistic interactions between endophytic cultivable bacterial communities isolated from the medicinal plant Echinacea purpurea.

Authors:  Isabel Maida; Carolina Chiellini; Alessio Mengoni; Emanuele Bosi; Fabio Firenzuoli; Marco Fondi; Renato Fani
Journal:  Environ Microbiol       Date:  2015-07-22       Impact factor: 5.491

6.  The comprehensive antibiotic resistance database.

Authors:  Andrew G McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A Azad; Alison J Baylay; Kirandeep Bhullar; Marc J Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M King; Kalinka Koteva; Mariya Morar; Michael R Mulvey; Jonathan S O'Brien; Andrew C Pawlowski; Laura J V Piddock; Peter Spanogiannopoulos; Arlene D Sutherland; Irene Tang; Patricia L Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

7.  Antibiotic resistance differentiates Echinacea purpurea endophytic bacterial communities with respect to plant organs.

Authors:  Alessio Mengoni; Isabel Maida; Carolina Chiellini; Giovanni Emiliani; Stefano Mocali; Arturo Fabiani; Marco Fondi; Fabio Firenzuoli; Renato Fani
Journal:  Res Microbiol       Date:  2014-10-02       Impact factor: 3.992

8.  Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.

Authors:  Carolina Chiellini; Isabel Maida; Valentina Maggini; Emanuele Bosi; Stefano Mocali; Giovanni Emiliani; Elena Perrin; Fabio Firenzuoli; Alessio Mengoni; Renato Fani
Journal:  Microbiol Res       Date:  2016-12-15       Impact factor: 5.415

9.  antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences.

Authors:  Marnix H Medema; Kai Blin; Peter Cimermancic; Victor de Jager; Piotr Zakrzewski; Michael A Fischbach; Tilmann Weber; Eriko Takano; Rainer Breitling
Journal:  Nucleic Acids Res       Date:  2011-06-14       Impact factor: 16.971

Review 10.  Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.

Authors:  James B Hudson
Journal:  J Biomed Biotechnol       Date:  2011-10-26
  10 in total
  1 in total

1.  Discovery of Phloeophagus Beetles as a Source of Pseudomonas Strains That Produce Potentially New Bioactive Substances and Description of Pseudomonas bohemica sp. nov.

Authors:  Zaki Saati-Santamaría; Rubén López-Mondéjar; Alejandro Jiménez-Gómez; Alexandra Díez-Méndez; Tomáš Větrovský; José M Igual; Encarna Velázquez; Miroslav Kolarik; Raúl Rivas; Paula García-Fraile
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.